ARCT Overview

Company Profile

Related stocks

CBIO • United States

Crescent Biopharma, Inc.

14.91 USD

553.86M USD 1Y +17.1%

SLDB • United States

Solid Biosciences Inc.

6.87 USD

736.64M USD 1Y +8.1%

SGP • United States

SpyGlass Pharma, Inc.

24.92 USD

833.52M USD

PRME • United States

Prime Medicine, Inc.

3.99 USD

723.69M USD 1Y -44.5%

CTMX • United States

CytomX Therapeutics, Inc.

2.57 USD

560M USD 1Y -26.7%

ODTX • United States

Odyssey Therapeutics, Inc.

19 USD

913.11M USD

JBIO • United States

Jade Biosciences, Inc.

14.39 USD

915.17M USD 1Y +55.8%

NGNE • United States

Neurogene Inc.

26.4 USD

528.3M USD 1Y +2.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

87.5% p.a.

Max Drawdown (5Y)

-88.4%

Sharpe Ratio (5Y)

-0.27

Beta Factor

2.48

Size Class

Small Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

High market risk: Beta of 2.48 indicates above-average volatility compared to the broader market.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (87.5% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -95.5% in the extended horizon.